About the company

Federal State Unitary Enterprise «Saint Petersburg Scientific Research Institute of Vaccines and Sera and Enterprise for the Production of Bacterial Preparations» of the Federal Medical and Biologic Agency (FSUE SPbSRIVS FMBA) is the Russian developer and manufacturer of pharmaceutical products according to the full cycle technology.

Saint Petersburg Scientific Research Institute of Vaccines and Sera is included in the list of strategic enterprises of pharmaceutical and medical industry. The Institute makes a significant contribution to the industrial and trade potential of the Russian Federation.

SPbSRIVS brochure

PDF

Our mission

Development and production of safe, effective and competitive in the domestic and world markets means for prevention and treatment of infectious diseases.

Areas of current activity

Influenza vaccines

«Flu-M» and «Flu-M Tetra»

Recombinant pharmaceutical products

«Convacell» vaccine, a recombinant component of the vaccine for the prevention of meningococcal infections

Polysaccharide conjugate pharmaceutical products

Vaccines for the prevention of pneumococcal infections, meningococcal infections and hemophilic infection type b "Baby- Hib"

Diagnostics manufacturing

Including purified tuberculosis allergen for Mantoux test

Modern filling and packaging

Including contract manufacturing

Our values

Quality

The reputation of any pharmaceutical company rests on its compliance with generally accepted quality standards. Trust to the manufacturer is built on the quality and efficiency of its products. Working for the benefit of human health, the Saint Petersburg Research Institute of Vaccines and Sera strictly monitors and constantly improves these parameters.

Commitment to innovation

Commitment to innovation makes us a competitive company. By using best practices in the development, production and management, we can develop and manufacture pharmaceutical products that are in demand on the market. Social responsibility does not allow us to be stagnant.

Employees

Behind every idea is a person. Our corporate culture is built on values that help us create an atmosphere of warmth and cohesion within the team, because teamwork allows us to achieve magnificent results! We believe that staff development within the company, the country and the world is the key to the success of the entire enterprise. We appreciate each employee. Potential development is one of our core values.

Stability

Long-term success comes from the decisions we make every day. Stability for us means not only financial reliability, but also production capacity and continuous development of our personnel. We create stability through decent wages, comfortable social benefits and ergonomic working conditions.

Figures and Facts

More than 600 highly qualified employees

The production meets international GMP quality standards

Three production technology platforms

Supplier of vaccines for the National Calendar of Preventive Vaccinations of the Russian Federation

The only Russian exporter of influenza vaccine to far-abroad countries

Developer of the only Russian influenza vaccine prequalified by WHO

International cooperation

Saint-Petersburg Scientific Research Institute of Vaccines and Sera collaborates with leading international vaccine developers and is a member of international organizations:

Developing Countries Vaccine Manufacturers Network

International Federation of Pharmaceutical Manufacturers and Associations Influenza Vaccine Supply Task Force

Emerging Biopharmaceutical Manufacturers Network, a global organization lobbying interests of biopharmaceutical manufacturers on the global stage

SPbSRIVS experts are members of WHO influenza vaccine working groups implemented in collaboration with IFPMA:

Potency assays for neuraminidase
Potency assays and reagents working group